European Journal of Cancer Supplements, 1359-6349

Tidskrift

Fler filtreringsmöjligheter
  1. Artikel i vetenskaplig tidskrift
  2. Adjuvant radiotherapy after radical prostatectomy

    Dirk Bottke, Per-Anders Abrahamsson, Birgitta Welte & Thomas Wiegel, 2007, I : European Journal of Cancer Supplements. 5, 5, s. 171-176

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. E28. Breast tolerance, tibolone compared to other hormonal treatments

    Hakan L. Olsson, 2004 dec, I : European Journal of Cancer, Supplement. 2, 9 SPEC. ISS., s. 79-80 2 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Publicerat konferensabstract
  5. Exposure to environmental tobacco smoke in childhood and incidence for selected cancers in adulthood: an analysis in the European prospective investigation into cancer and nutrition

    S. C. Chuang, V. Gallo, A. Tjonneland, K. Overvad, D. Palli, V. Pala, P. H. Peeters, Jonas Manjer & P. Vineis, 2010, I : EJC Supplements. 8, 5, s. 86

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  6. Epigenetic target genes in malignant peripheral nerve sheath tumours identified as surrogate prognostic biomarkers

    S. Aske Danielsen, G. E. Lind, K. Sundby Hall, S. Smeland, E. van den Berg, Fredrik Mertens, M. Kolberg & R. A. Lothe, 2010, I : EJC Supplements. 8, 5, s. 163

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  7. Early breast cancer detection: validation of a commercially available blood-based gene expression test

    D. Tobin, N. Hagen, A. L. Borresen-Dale, A. Hollingsworth, E. Schlicting, P. Skaane, F. Warnberg, L. Bergkvist, Christian Ingvar & P. E. Jonsson, 2010, I : EJC Supplements. 8, 3, s. 110-110

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  8. Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5

    C. E. Ford, J. Tuomela, E. L. Hedditch, Lena Axelsson, Qing Liu, R. L. Ward, P. Harkonen & Tommy Andersson, 2010, I : EJC Supplements. 8, 5, s. 43

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  9. Ki67 proliferation as a biomarker in neo-adjuvant breast cancer studies - core biopsy versus surgical sample

    Signe Borgquist, Quinci Romero, Pär-Ola Bendahl & Dorthe Grabau, 2010, I : EJC Supplements. 8, 3, s. 169-169

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  10. Prognostic value of gene expression targeted by gain of 17q sequences in malignant peripheral nerve sheath tumours

    M. Kolberg, T. H. Agesen, M. Holand, H. R. Brekke, R. I. Skotheim, K. S. Hall, E. van den Berg, Fredrik Mertens, S. Smeland & R. A. Lothe, 2010, I : EJC Supplements. 8, 5, s. 122

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  11. Validation study of the prognostic significance of beta-microseminoprotein and cysteine-rich secretory protein-3 after radical prostatectomy using automated image analysis

    Anna K Dahlman, E. Rexhepaj, D. Brennan, W. Gallagher, T. Schlomm, Karin Jirström & Anders Bjartell, 2010, I : EJC Supplements. 8, 5, s. 136

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  12. Cyclin A - an alternative to gene expression profiling for subdividing histological grade 2 breast cancer into groups with different prognosis

    Carina Forsare, Anette AhlinGullers, M. L. Fjallskog, P. Malmstrom & Mårten Fernö, 2010, I : EJC Supplements. 8, 3, s. 95-96

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  13. Is duration of breastfeeding related to risk of different breast cancer subgroups?

    Salma Butt, Signe Borgquist, Theano Anagnostaki, Göran Landberg & Jonas Manjer, 2010, I : EJC Supplements. 8, 3, s. 206-207

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  14. Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells

    R. Bjerkvig, S. K. Leivonen, P. Ostling, A. Aakula, P. Kohonen, R. Makela, Zandra Hagman, H. Edgren, Yvonne Ceder, M. Perala & O. Kallioniemi, 2010, I : EJC Supplements. 8, 7, s. 177-177

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  15. Parity and age at first childbirth in relation to the risk of different breast cancer subgroups

    Salma Butt, Signe Borgquist, Theano Anagnostaki, Göran Landberg & Jonas Manjer, 2010, I : EJC Supplements. 8, 3, s. 209-209

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  16. Ki-67 as a long-term prognostic factor in lobular breast cancer

    Ulrik Narbe, Pär-Ola Bendahl, Dorthe Grabau, Lisa Rydén, Mårten Fernö & Christian Ingvar, 2010, I : EJC Supplements. 8, 3, s. 98-98

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  17. Interim analysis of epidermal-growth factor receptor (EGFR) expression in a single-arm, phase II, first-line study (20060314) of panitumumab with FOLFIRI in the management of metastatic colorectal cancer (mCRC)

    C. Koehne, R. Hofheinz, L. Mineur, H. Letocha, R. Greil, J. Thaler, E. Gamelin, Eva Fernebro, L. Wright & M. Karthaus, 2009, I : EJC Supplements. 7, 2, s. 343-344

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  18. Pattern of use of second-line treatment for NSCLC in the Nordic countries

    A. Mellemgaard, Lars Ek, H. Riska & R. Tell, 2009, I : EJC Supplements. 7, 2, s. 527-527

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  19. Feelings of loss and shame after having lost a testicle: a population-based long-term follow-up of testicular-cancer survivors

    J. S. Skoogh, G. S. Steineck, Eva Cavallin-Ståhl, U. O. UIrica Olofsson, M. L. Magnus Lindwall, Ulf Håkansson, B. J. Boo Johansson & U. S. Ulrika Stierner, 2009, I : EJC Supplements. 7, 2, s. 445-445

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  20. Increased cardiovascular morbidity and mortality following endocrine treatment for prostate cancer: an analysis in 30,642 men in PCBaSe Sweden

    M. Van Hemelrijck, H. Garmo, Ola Bratt, A. Bill-Axelson, M. Lambe, P. Stattin, L. Holmberg & J. Adolfsson, 2009, I : EJC Supplements. 7, 3, s. 1-1

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  21. EUROCOURSE: towards optimisation of the use of cancer registries for scientific excellence in cancer research in Europe: an FP7 ERA-net project

    J. Coebergh, C. J. G. van den Hurk, H. H. Storm, R. Zanetti, H. Comber, A. Antilla, Joakim Dillner, F. Bray, S. Siesling & E. Steliarova-Foucher, 2009, I : EJC Supplements. 7, 2, s. 201-202

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  22. Organisational hazards when treating patients with cytotoxic drugs

    Sven Ternov, AnnSofie Fyhr & Roland Akselsson, 2009, I : EJC Supplements. 7, 2, s. 210-210

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  23. Lactoferricin treatment delays cell cycle progression of a human colon cancer cell line

    Catja Freiburghaus, Helena Lindmark Månsson, Stina Oredsson & Marie Paulsson, 2008, I : EJC Supplements. 6, 9, s. 150-150

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  24. Polyamine analogue treatment of neuroblastoma

    Erika Söderstjerna, K. Hellman & Stina Oredsson, 2008, I : EJC Supplements. 6, 9, s. 133-133

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  25. Anti proliferative activity on human colon cancer cells treated in vitro with extracts from Bolivian foods and other plants

    G. Rodrigo, G. Almanza, Rui-Dong Duan & Björn Åkesson, 2008, I : EJC Supplements. 6, 9, s. 198-198

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  26. A randomized feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer

    S Margolin, L Carlsson, M Hellström, P Karlsson, E Lidbrink, B Linderholm, H Lindman, Per Malmström, D Sköld Pettersson & J Bergh, 2008, I : European Journal of Cancer Supplements. 6, 7, s. 116-117

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  27. Systematic validation of novel breast cancer progression-associated biomarkers via high-throughput antibody generation and application of tissue microarray technology

    S A Penny, C M Kelly, D J Brennan, A C Culhane, D G Higgins, P A Dervan, Karin Jirström, F Ponten, M Uhlen & W M Gallagher, 2008, I : European Journal of Cancer Supplements. 6, 7, s. 59-59

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract